Skip to content

Effects of Vitamin E on the treatment of atopic dermatitis

Evaluating the effects of oral vitamin E on the treatment of atopic dermatitis and comparing with placebo

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
IRCT
Registry ID
IRCT201105016350N1
Enrollment
70
Registered
2011-05-31
Start date
2009-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis. Atopic dermatitis

Interventions

Intervention 1: intervention group: vitamin E tablet 400 IU/ oral/ /daily/ I /for 4 months. Intervention 2: control group: placebo tablet/ oral/daily/ I/ for 4 months.
Treatment - Drugs
Placebo
intervention group: vitamin E tablet 400 IU/ oral/ /daily/ I /for 4 months
control group: placebo tablet/ oral/daily/ I/ for 4 months

Sponsors

Vice chancellery for research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: All people with atopic dermatitis based on the Hanifin and Rajka’s diagnostic criteria in age range of 10-50 years except these: 1-Lactating woman, 2- Pregnant woman, 3- Severe form of a disease with scored index of more than 50, 4-Taking systemic corticosteroid or immunosuppressive drugs, 5- Coagulopathy, 6- Need to hospitalization, 7- History of allergy to vitamin E. Exclushion criteria: 1- Getting pregnant during the treatment period, 2- Exacerbation of the disease, 3- Allergy symptoms to vitamin E.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sleep. Timepoint: Monthly. Method of measurement: Visual analogue scale 0-10.;Itch. Timepoint: Monthly. Method of measurement: Visual analogue scale 0-10.;Extent of lesions. Timepoint: Monthly. Method of measurement: Transparent paper rating based on unit area.

Secondary

MeasureTime frame
Gastrointestinal symptoms after taking vitamin E. Timepoint: monthly. Method of measurement: Questionnaire.;Skin rash or any new skin symptom. Timepoint: monthly. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Gita Faghihi

Isfahan university of medical sciences

g_faghihi@med.mui.ac.ir+98 913 401 3789

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026